08/23/2022 / PRZen / SALEM, Mass. — Commonwealth Diagnostics International, Inc. (CDI)an innovative GI healthcare company that offers industry-leading diagnostic tests and tools to help physicians identify and diagnose common sources of digestive disorders and functional gastrointestinal conditions, today announced expanded access to the naturopathic and integrative medicine community through a strategic partnership with known Rupa healtha digital health platform that makes it easier to practice causal medicine through a streamlined process for ordering specialty labs.

“We are thrilled to partner with Rupa Health and look forward to working together to provide patients with diagnostic care when and where they need it,” he said Craig S. Strasnick, President and CEO of CDI. “Delivering CDI’s cost-effective diagnostic solutions on the Rupa platform will provide greater access to naturopathic and integrative practitioners and their patients across the country, helping to expedite treatments with more accurate and timely results from our experienced laboratory staff.”

As part of the strategic partnership, Rupa will provide services including marketing support and order fulfillment services to CDI’s portfolio of industry-leading diagnostic solutions. Tests now available to order on the Rupa platform include non-invasive at-home hydrogen and methane breath tests for Small Intestinal Bacterial Overgrowth (SIBO) and Intestinal Methanogen Overgrowth (IMO), as well as fructose, lactose and sucrose -Malabsorption.

Strasnick continues: “The holistic approach to health, wellness and nutrition places great value on the prevention of diseases. A central aspect of this approach is that good health goes hand in hand with good…